# EDGAR Filing Document

**Accession Number:** 0000096885
**File Stem:** 0001185185-23-000114
**Filing Date:** 2023-2
**Character Count:** 112673
**Document Hash:** a4c4b89919ea0c04ed747cf70d1227aa
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001185185-23-000114.hdr.sgml**: 20230213

**ACCESSION NUMBER**: 0001185185-23-000114

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 66

**CONFORMED PERIOD OF REPORT**: 20221231

**FILED AS OF DATE**: 20230213

**DATE AS OF CHANGE**: 20230213

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** TEL INSTRUMENT ELECTRONICS CORP
- **CENTRAL INDEX KEY:** 0000096885
- **STANDARD INDUSTRIAL CLASSIFICATION:** ELECTRONIC COMPONENTS & ACCESSORIES [3670]
- **IRS NUMBER:** 221441806
- **STATE OF INCORPORATION:** NJ
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-31990
- **FILM NUMBER:** 23614894

**BUSINESS ADDRESS:**
- **STREET 1:** ONE BRANCA ROAD
- **CITY:** EAST RUTHERFORD
- **STATE:** NJ
- **ZIP:** 07073
- **BUSINESS PHONE:** 2019331600

**MAIL ADDRESS:**
- **STREET 1:** ONE BRANCA ROAD
- **CITY:** EAST RUTHERFORD
- **STATE:** NJ
- **ZIP:** 07073

?xml version="1.0" encoding="ASCII"? telinstru20221231_10q.htm

------

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

------

**FORM 10-Q**

------

**☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

For the quarterly period ended: **<u>December 31, 2022</u>**

**☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

Commission File Number: **<u>001-31990</u>**

**<u>TEL-INSTRUMENT ELECTRONICS CORP.</u>**

(Exact name of registrant as specified in its charter)

---

| | |
|:---|:---|
| **<u>New Jersey</u>** | **<u>22-1441806</u>** |
| (State or other jurisdiction of<br> incorporation or organization) | (I.R.S. Employer<br> Identification No.) |

---

---

| |
|:---|
| **One Branca Road**<br> **<u>East Rutherford, NJ 07073</u>** |
| (Address of principal executive offices) |

---

---

| |
|:---|
| **<u>(201) 933-1600</u>** |
| (Registrant's telephone number, including area code) |

---

**Securities registered pursuant to Section 12(b) of the Act:**

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| N/A | N/A | N/A |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months, and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large, accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of "large, accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large, accelerated filer ☐ Accelerated filer ☐ <br> Non-accelerated filer ☒ Smaller reporting company ☒ <br> Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of February 10, 2023, there were 3,255,887 shares outstanding of the registrant's common stock.

------

**TEL-INSTRUMENT ELECTRONICS CORP.**

**TABLE OF CONTENTS**

---

| | | |
|:---|:---|:---|
| **PART I** – **FINANCIAL INFORMATION** | **PART I** – **FINANCIAL INFORMATION** | **PART I** – **FINANCIAL INFORMATION** |
|  |  | **Page** |
| Item 1. | [Unaudited Condensed Consolidated Financial Statements.](#a1) | 3 |
| Item 2. | [Management's Discussion and Analysis of Financial Condition and Results of Operations.](#a2) | 21 |
| Item 3. | [Quantitative and Qualitative Disclosures About Market Risk.](#a3) | 26 |
| Item 4. | [Controls and Procedures.](#a4) | 26 |
| **PART II** – **OTHER INFORMATION** | **PART II** – **OTHER INFORMATION** | **PART II** – **OTHER INFORMATION** |
| Item 1. | [Legal Proceedings.](#a21) | 27 |
| Item 1A. | [Risk Factors.](#a21a) | 27 |
| Item 2. | [Unregistered Sales of Equity Securities and Use of Proceeds.](#a22) | 27 |
| Item 3. | [Defaults Upon Senior Securities.](#a23) | 27 |
| Item 4. | [Mine Safety Disclosures.](#a24) | 27 |
| Item 5. | [Other Information.](#a25) | 28 |
| Item 6. | [Exhibits.](#a26) | 28 |
| [Signatures](#sigs) | [Signatures](#sigs) | 29 |

---

------

**PART I** – **FINANCIAL INFORMATION**

**Item 1. Unaudited Condensed Consolidated Financial Statements.**

**<u>TEL-INSTRUMENT ELECTRONICS CORP.</u>**

**<u>CONDENSED CONSOLIDATED BALANCE SHEETS</u>**

---

| | | |
|:---|:---|:---|
|  | **December 31,** <br> **2022** | **March 31,**<br> **2022** |
|  | (unaudited) |  |
| ASSETS |  |  |
| Current assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cash | $3292547 | $4949690 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accounts receivable, net | 1270353 | 1049040 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inventories, net | 3311159 | 2820497 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Restricted cash to support appeal bond | 2011050 | 2011050 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Prepaid expenses and other current assets | 967612 | 244040 |
| Total current assets | 10852721 | 11074317 |
| Equipment and leasehold improvements, net | 81921 | 115338 |
| Operating lease right-of-use assets | 1575377 | 1720921 |
| Deferred tax asset, net | 2584036 | 2499587 |
| Other long-term assets | 35109 | 35109 |
| Total assets | $15129164 | $15445272 |
| LIABILITIES & STOCKHOLDERS' EQUITY |  |  |
| Current liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Operating lease liabilities – current portion | $200148 | $194370 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accounts payable | 563414 | 406489 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Deferred revenues - current portion | 167672 | 119835 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accrued expenses - vacation pay, payroll and payroll withholdings | 217461 | 410538 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accrued legal damages | 6291226 | 6097273 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accrued expenses - other | 270107 | 174145 |
| Total current liabilities | 7710028 | 7402650 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Operating lease liabilities – long-term | 1375229 | 1526551 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Deferred revenues – long-term | 195814 | 289071 |
| Total liabilities | 9281071 | 9218272 |
| Commitments and contingencies |  |  |
| Stockholders' equity: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Preferred stock, 1,000,000 shares authorized, par value $0.10 per share |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Preferred stock, 500,000 shares 8% Cumulative Series A Convertible Preferred<br> authorized, issued and outstanding, par value $0.10 per share | 3815998 | 3695998 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Preferred stock, 166,667 shares 8% Cumulative Series B Convertible Preferred<br> authorized, issued and outstanding, par value $0.10 per share | 1187367 | 1147367 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Common stock, 7,000,000 shares authorized, par value $0.10 per share,<br> 3,255,887 and 3,255,887 shares issued and outstanding, respectively | 325586 | 325586 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Additional paid-in capital | 6797056 | 7018353 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accumulated deficit | (6277914) | (5960304) |
| Total stockholders' equity | 5848093 | 6227000 |
| Total liabilities and stockholders' equity | $15129164 | $15445272 |

---

See accompanying notes to unaudited condensed consolidated financial statements.

------

[**Table of Contents**](#toc)

**<u>TEL-INSTRUMENT ELECTRONICS CORP.</u>**

**<u>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</u>**

**(Unaudited)**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
|  | **December 31,** <br> **2022** | **December 31,** <br> **2021** | **December 31,** <br> **2022** | **December 31,** <br> **2021** |
| Net sales | $2328254 | $3171532 | $6594768 | $10914787 |
| Cost of sales | 1434547 | 1763739 | 4312405 | 5824341 |
| Gross margin | 893707 | 1407793 | 2282363 | 5090446 |
| Operating expenses: |  |  |  |  |
| Selling, general and administrative | 578077 | 523966 | 1613021 | 1674618 |
| Litigation expenses | 10860 | 17145 | 12102 | 21545 |
| Engineering, research, and development | 370795 | 574118 | 1502534 | 1950545 |
| Total operating expenses | 959732 | 1115229 | 3127657 | 3646708 |
| (Loss) income from operations | (66025) | 292564 | (845294) | 1443738 |
| Other income (expense): |  |  |  |  |
| Interest income | 5664 | 996 | 8787 | 2977 |
| Other income | 628400 |  | 628400 | 35854 |
| Gain on forgiveness of PPP loan |  |  |  | 722577 |
| Interest expense – judgement | (71016) | (52490) | (193952) | (156901) |
| Total other net income (expense) | 563048 | (51494) | 443235 | 604507 |
| Income (loss) before income taxes | 497023 | 241070 | (402059) | 2048245 |
| Income tax expense (benefit) | 104396 | 46448 | (84449) | 278446 |
| Net income (loss) | 392627 | 194622 | (317610) | 1769799 |
| Preferred dividends | (80000) | (80000) | (240000) | (240000) |
| Net income (loss) attributable to common shareholders | $312627 | $114622 | $(557610) | $1529799 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Basic net income (loss) per common share | $0.10 | $0.04 | $(0.17) | $0.47 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Diluted net income (loss) per common share | $0.08 | $0.04 | $(0.17) | $0.35 |
| Weighted average shares outstanding: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Basic | 3255887 | 3255887 | 3255887 | 3255887 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Diluted | 5155665 | 5095665 | 3255887 | 5095665 |

---

See accompanying notes to unaudited condensed consolidated financial statements.

------

[**Table of Contents**](#toc)

**<u>TEL-INSTRUMENT ELECTRONICS CORP.</u>**

**<u>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS</u>**' **<u>EQUITY</u>**

**For the Three Months Ended December 31, 2022, and 2021**

**(Unaudited)**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Series A Convertible** <br> **Preferred Stock** | **Series A Convertible** <br> **Preferred Stock** | **Series B Convertible** <br> **Preferred Stock** | **Series B Convertible** <br> **Preferred Stock** | **Common Stock** | **Common Stock** | **Additional** <br> **Paid-In**<br> **Capital** | <br> **Accumulated**<br> **Deficit** | <br> **Total**  |
|  | **# of Shares** <br> **Issued** | **Amount** | **# of Shares** <br> **Issued** | **Amount** | **# of Shares** <br> **Issued** | **Amount**  | **Additional** <br> **Paid-In**<br> **Capital** | <br> **Accumulated**<br> **Deficit** | <br> **Total**  |
| **Balances at October 1, 2022** | 500000 | $3755998 | 166667 | $1167367 | 3255887 | $325586 | $6870822 | $(6670541) | $5449232 |
| 8% Dividends on Preferred Stock | **-** | 60000 | **-** | 20000 | **-** | **-** | (80000) |  |  |
| Dividend Payments | **-** |  | **-** |  | **-** | **-** |  |  |  |
| Stock-based compensation | **-** | **-** | **-** | **-** | **-** | **-** | 6234 |  | 6234 |
| Net income |  |  |  |  |  |  |  | 392627 | 392627 |
| **Balances at December 31, 2022** | 500000 | $3815998 | 166667 | $1187367 | 3255887 | $325586 | $6797056 | $(6277914) | $5848093 |

---

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Series A Convertible** <br> **Preferred Stock** | **Series A Convertible** <br> **Preferred Stock** | **Series B Convertible** <br> **Preferred Stock** | **Series B Convertible** <br> **Preferred Stock** | **Common Stock** | **Common Stock** | **Additional** <br> **Paid-In**<br> **Capital** | <br> **Accumulated**<br> **Deficit**  | <br> **Total**  |
|  | **# of Shares** <br> **Issued** | **Amount** | **# of Shares** <br> **Issued** | **Amount** | **# of Shares** <br> **Issued** | **Amount** | **Additional** <br> **Paid-In**<br> **Capital** | <br> **Accumulated**<br> **Deficit**  | <br> **Total**  |
| **Balances at October 1, 2021** | 500000 | $3695998 | 166667 | $1147367 | 3255887 | $325586 | $7170954 | $(5694865) | $6645040 |
| 8% Dividends on Preferred Stock | **-** | 60000 | **-** | 20000 | **-** | **-** | (80000) | **-** | **-** |
| Dividend Payments | **-** | (60000) | **-** | (20000) | **-** | **-** |  |  | (80000) |
| Stock-based compensation | **-** |  | **-** | **-** | **-** | **-** | 7514 |  | 7514 |
| Net income |  |  |  |  |  |  |  | 194622 | 194622 |
| **Balances at December 31, 2021** | 500000 | $3695998 | 166667 | $1147367 | 3255887 | $325586 | $7098468 | $(5500243) | $6767176 |

---

See accompanying notes to unaudited condensed consolidated financial statements.

------

[**Table of Contents**](#toc)

**<u>TEL-INSTRUMENT ELECTRONICS CORP.</u>**

**<u>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS</u>**' **<u>EQUITY</u>**

**For the Nine Months Ended December 31, 2022, and 2021**

**(Unaudited)**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Series A Convertible** <br> **Preferred Stock** | **Series A Convertible** <br> **Preferred Stock** | **Series B Convertible** <br> **Preferred Stock** | **Series B Convertible** <br> **Preferred Stock** | **Common Stock** | **Common Stock** | **Additional** <br> **Paid-In**<br> **Capital**  | <br> **Accumulated**<br> **Deficit**  | <br> **Total** |
|  | **# of Shares** <br> **Issued** | **Amount** | **# of Shares** <br> **Issued** | **Amount** | **# of Shares** <br> **Issued** | **Amount** | **Additional** <br> **Paid-In**<br> **Capital**  | <br> **Accumulated**<br> **Deficit**  | <br> **Total** |
| **Balances at April 1, 2022** | 500000 | $3695998 | 166667 | $1147367 | 3255887 | $325586 | $7018353 | $(5960304) | $6227000 |
| 8% Dividends on Preferred Stock | **-** | 180000 | **-** | 60000 | **-** | **-** | (240000) |  |  |
| Dividend Payments | **-** | (60000) | **-** | (20000) | **-** | **-** |  |  | (80000) |
| Stock-based compensation | **-** | **-** | **-** | **-** | **-** | **-** | 18703 |  | 18703 |
| Net loss |  |  |  |  |  |  |  | (317610) | (317610) |
| **Balances at December 31, 2022** | 500000 | $3815998 | 166667 | $1187367 | 3255887 | $325586 | $6797056 | $(6277914) | $5848093 |

---

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Series A Convertible** <br> **Preferred Stock** | **Series A Convertible** <br> **Preferred Stock** | **Series B Convertible** <br> **Preferred Stock** | **Series B Convertible** <br> **Preferred Stock** | **Common Stock** | **Common Stock** | **Additional** <br> **Paid-In**<br> **Capital**  | <br> **Accumulated**<br> **Deficit**  | <br> **Total**  |
|  | **# of Shares** <br> **Issued** | **Amount** | **# of Shares** <br> **Issued** | **Amount** | **# of Shares** <br> **Issued** | **Amount** | **Additional** <br> **Paid-In**<br> **Capital**  | <br> **Accumulated**<br> **Deficit**  | <br> **Total**  |
| **Balances at April 1, 2021** | 500000 | $3695998 | 166667 | $1147367 | 3255887 | $325586 | $7318620 | $(7270042) | $5217529 |
| 8% Dividends on Preferred Stock | **-** | 180000 | **-** | 60000 | **-** | **-** | (240000) | **-** | **-** |
| Dividend Payments | **-** | (180000) |  | (60000) | **-** | **-** |  |  | (240000) |
| Stock-based compensation | **-** | **-** | **-** | **-** | **-** | **-** | 19848 |  | 19848 |
| Net income |  |  |  |  |  |  |  | 1769799 | 1769799 |
| **Balances at December 31, 2021** | 500000 | $3695998 | 166667 | $1147367 | 3255887 | $325586 | $7098468 | $(5500243) | $6767176 |

---

See accompanying notes to unaudited condensed consolidated financial statements.

------

[**Table of Contents**](#toc)

**<u>TEL-INSTRUMENT ELECTRONICS CORP.</u>**

**<u>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</u>**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
|  | **Nine Months Ended** | **Nine Months Ended** |
|  | **December 31,** <br> **2022** | **December 31,** <br> **2021** |
| Cash flows from operating activities: |  |  |
| Net (loss) income | $(317610) | $1769799 |
| Adjustments to reconcile net (loss) income to net cash provided by (used in) operating activities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Deferred income taxes | (84449) | 278447 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Depreciation and amortization | 39553 | 78225 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Amortization of right of use assets | 145544 | 154462 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (Recovery of) provision for inventory obsolescence | (8068) | 25000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Forgiveness of PPP Loan |  | (722577) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Non-cash stock-based compensation | 18703 | 19848 |
| Changes in assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Increase) decrease in accounts receivable | (221313) | 547937 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Increase) decrease in inventories | (482594) | 664714 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Increase) in prepaid expenses & other assets | (723572) | (23440) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Decrease (increase) in accounts payable and other accrued liabilities | 252887 | (613440) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Decrease in accrued payroll, vacation pay and payroll taxes | (193077) | (81159) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Decrease in deferred revenues | (45420) | (51944) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Decrease in operating lease liabilities | (145544) | (154461) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increase in accrued legal damages | 193953 | 156901 |
| Net cash (used in) provided by operating activities | (1571007) | 2048312 |
| Cash flows from investing activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Purchases of equipment | (6136) | (4777) |
| Net cash used in investing activities | (6136) | (4777) |
| Cash flows from financing activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Payment of dividends | (80000) | (240000) |
| Net cash used in financing activities | (80000) | (240000) |
| Net (decrease) increase in cash and restricted cash | (1657143) | 1803535 |
| Cash and restricted cash at beginning of period | 6960740 | 5496325 |
| Cash and restricted cash at end of period | $5303597 | $7299860 |
| <u>End of period</u> |  |  |
| Cash | $3292547 | $5288810 |
| Restricted cash | 2011050 | 2011050 |
|  | $5303597 | $7299860 |
| <u>Beginning of period</u> |  |  |
| Cash | $4949690 | $3485275 |
| Restricted cash | 2011050 | 2011050 |
|  | $6960740 | $5496325 |
| Supplemental cash flow information: |  |  |
| Taxes paid | $- |  |
| Interest paid | $- | $- |

---

See accompanying notes to unaudited condensed consolidated financial statements.

------

[**Table of Contents**](#toc)

**<u>TEL-INSTRUMENT ELECTRONICS CORP.</u>**

**<u>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</u>**

**(Unaudited)**

<u>Note 1</u> – <u>Business, Organization and Liquidity</u>

*Business and Organization*

Tel-Instrument Electronics Corp. ("Tel," "TIC" or the "Company") has been in business since 1947. The Company is a leading designer and manufacturer of avionics test and measurement instruments for the global, commercial air transport, general aviation, and government/military defense markets. Tel provides instruments to test, measure, calibrate, and repair a wide range of airborne navigation and communication equipment. The Company sells its equipment in both domestic and international markets. Tel continues to develop new products in anticipation of customers' needs and to maintain its strong market position. Its development of multi-function testers has made it easier for customers to perform ramp tests with less operator training, fewer test sets, and lower product support costs. The Company has become a major manufacturer and supplier of Identification Friend or Foe ("IFF") flight line test equipment over the last two decades.

The Company is publicly traded and was quoted on the Over-the-Counter Market Place ("OTCQB") under the symbol "TIKK."

*Liquidity* 

On December 31, 2022, the Company had positive working capital of $3,142,693 as compared to working capital of $3,671,667 on March 31, 2022. This included approximately $5.3 million of cash including the $2 million restricted cash supporting the appeal bond. The Company has recorded total damages of $6,291,226 including accrued interest, as a result of the jury verdict associated with the Aeroflex litigation.

The Company had a $5.6 million backlog on December 31, 2022.

Bank of America renewed the Company line of credit with a maturity date of July 30, 2023. As of December 31, 2022, the line of credit draw remains at zero, with $690,000 available.

Moving forward, we believe that our expected cash flows from operations and current cash balances, which amounted to approximately $5.3 million, including the approximately $2 million in restricted cash will be sufficient to operate in the normal course of business for the next 12 months from the issuance date of these unaudited condensed consolidated financial statements, including any payments for settlement of the litigation. After five quarters of severe supply chain disruption, the Company has started to see gradual improvement in parts availability, however on average long delivery timelines remain an issue. The Company has been mitigating this long lasting critical issue by placing perpetual supplier orders to stock production inventory for confirmed customer orders and projections.

Currently, the Company has no material future capital expenditure requirements.

*Impact of the COVID-19 Coronavirus* 

In December 2019, a novel strain of coronavirus, which causes the disease known as COVID-19, was reported to have surfaced in Wuhan, China. Since then, COVID-19 coronavirus has spread globally. In March 2020, the World Health Organization declared the COVID-19 outbreak a pandemic and the U.S. government imposed travel restrictions on travel between the United States, Europe, and certain other countries. The impact of this pandemic has been, and will likely continue to be, extensive in many aspects of society, which has resulted, and will likely continue to result, in significant disruptions to the global economy as well as businesses and capital markets around the world.

------

[**Table of Contents**](#toc)

**<u>TEL-INSTRUMENT ELECTRONICS CORP.</u>**

**<u>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</u>**

**(Unaudited)**

<u>Note 1</u> – <u>Business, Organization and Liquidity (continued)</u>

*Impact of the COVID-19 Coronavirus (continued)*

On September 9, 2021, President Biden announced Executive Order 14042 ("Executive Order") and related initiatives designed to lead the country out of the COVID-19 pandemic. The Executive Order includes policies that will require employees of contractors that do business with the federal government to be vaccinated. On September 24, 2021, The Safer Federal Workforce Task Force released COVID-19 vaccine guidance for Federal contractors and subcontractors. According to this guidance, covered employees must be fully vaccinated by December 8, 2021, or at the latest, by the first day of performance on a covered contract, absent the need for a disability or religious accommodation. In addition, covered contractors must follow the CDC's mask and physical distance requirements for covered contractor employees and visitors. The Executive Order and the guidance apply to any prime contractor or subcontractor that is a party to a "contract or contract-like instrument" that includes a clause incorporating the requirements of the Executive Order. The new clause applied on or after October 15, 2021, to only new federal contracts, solicitations, contract extensions and renewals whose value exceeds $250,000. TIC currently does not have any federal contracts or similar contract-like instruments that are in excess of $250,000, however the vast majority of the TIC employees are fully vaccinated, and TIC is preparing for full compliance of the Executive Order should it apply.

<u>Note 2</u> – <u>Summary of Significant Accounting Policies</u>

*Basis of Presentation*

In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments necessary to present fairly the financial position of Tel-Instrument Electronics Corp. as of December 31, 2022, the results of operations and change in stockholders' equity for the three and nine months ended December 31, 2022 and December 31, 2021, and statements of cash flow for the nine months ended December 31, 2022 and December 31, 2021. These results are not necessarily indicative of the results to be expected for the full year. The unaudited condensed consolidated financial statements have been prepared in accordance with the requirements of Form 10-Q and consequently do not include disclosures normally made in an Annual Report on Form 10-K. The March 31, 2022, balance sheet included herein was derived from the audited financial statements included in the Company's Annual Report on Form 10-K as of that date. Accordingly, the unaudited condensed consolidated financial statements included herein should be reviewed in conjunction with the financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2022, as filed with the United States Securities and Exchange Commission (the "SEC") on June 17, 2022 (the "Annual Report").

*Revenue Recognition*

Under Financial Accounting Standards Board ("FASB") Topic 606, *Revenue from Contacts with Customers* ("ASC 606"), the Company recognizes revenue when the customer obtains control of promised goods or services, in an amount that reflects the consideration which is expected to be received in exchange for those goods or services. The Company recognizes revenue following the five-step model prescribed under ASC 606: (i) identify contract(s) with a customer; (ii) identify the performance obligation(s) in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligation(s) in the contract; and (v) recognize revenue when (or as) the Company satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods and services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.

The Company accounts for revenue recognition in accordance with ASC 606.The core principle of Topic 606 is to recognize revenues when promised goods or services are transferred to customers in an amount that reflects the consideration that is expected to be received for those goods or services. The ASC 606 defines a five-step process to achieve the core principle and, in doing so, it is possible more judgement and estimates may be required within the revenue recognition process than are currently in use.

The Company generates revenue from designing, manufacturing, and selling avionic tests and measurement solutions for the global commercial air transport, general aviation, and government/military aerospace and defense markets. The Company also offers calibration and repair services for a wide range of airborne navigation and communication equipment.

------

[**Table of Contents**](#toc)

**<u>TEL-INSTRUMENT ELECTRONICS CORP.</u>**

**<u>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</u>**

**(Unaudited)**

<u>Note 2</u> – <u>Summary of Significant Accounting Policies (continued)</u>

<u>Nature of goods and services</u>

The following is a description of the products and services from which the Company generates revenue, as well as the nature, timing of satisfaction of performance obligations, and significant payment terms for each.

*<u>Test Units/Sets</u>*

The Company develops and manufactures unit sets to test navigation and communication equipment, such as ramp testers and bench testers for equipment installed in aircraft and ground radios. The Company recognizes revenue when the customer obtains control of the Company's product based on the contractual shipping terms of the contract, which is usually at the time of shipment. Revenue on products is presented gross because the Company is primarily responsible for fulfilling the promise to provide the product, is responsible to ensure that the product is produced in accordance with the related supply agreement and bears the risk of loss while the inventory is in-transit. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products to the customer.

If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price based on the estimated relative standalone selling prices of the promised products or services underlying each performance obligation. The Company determines stand-alone selling prices based on the price at which the performance obligation is sold separately. If the stand-alone selling price is not observable through past transactions, the Company estimates the standalone selling price considering available information such as market conditions and internally approved pricing guidelines related to the performance obligations.

When determining the transaction price of a contract, an adjustment is made if payment from the customer occurs either significantly before or significantly after performance, resulting in a significant financing component. Applying the practical expedient in paragraph 606-10-32-18, the Company does not assess whether a significant financing component exists if the period between when the Company performs its obligations under the contract and when the customer pays is one year or less. None of the Company's contracts contained a significant financing component as of December 31, 2022.

*<u>Replacement Parts</u>*

The Company offers replacement parts for test equipment, ramp testers, and bench testers. Similar to the sale of test units, the control of the product transfers at a point of time and therefore, revenue is recognized at the point in time when the obligation to the customer has been fulfilled.

*<u>Extended Warranties</u>*

The extended warranties sold by the Company provide a level of assurance beyond the coverage for defects that existed at the time of a sale or against certain types of covered damage with coverage terms ranging from 2 to 7 years. Amounts received for warranties are recorded as deferred revenue and recognized as revenue ratably over the respective term of the agreements. As of December 31, 2022, $319,911 is expected to be recognized from remaining performance obligations for extended warranties as compared to $386,907 at March 31, 2022. For the three and nine months ended December 31, 2022, the Company recognized revenue of $24,393 and $71,796 respectively from amounts that were included in Deferred Revenue as compared to $20,267 and $52,249, respectively from amounts that were included in Deferred Revenue for the three months and nine months ended December 31, 2021.

The following table provides a summary of the changes in deferred revenues for the nine months ended December 31, 2022:

---

| | |
|:---|:---|
| Deferred revenues at April 1, 2022 | $386907 |
| Additional extended warranties | 4800 |
| Revenue recognized for the nine months ended December 31, 2022 | (71796) |
| Deferred revenues at December 31, 2022 | $319911 |

---

------

[**Table of Contents**](#toc)

**<u>TEL-INSTRUMENT ELECTRONICS CORP.</u>**

**<u>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</u>**

**(Unaudited)**

<u>Note 2</u> – <u>Summary of Significant Accounting Policies (continued)</u>

*<u>Other Deferred Revenues</u>*

The Company sometimes receives payments in advance of shipment. These amounts are classified as other deferred revenues. For the periods ended December 31, 2022, and March 31, 2022, the Company has other deferred revenues of $43,575 and $21,999, respectively.

*<u>Repair and Calibration Services</u>*

The Company offers repair and calibration services for units that are returned for annual calibrations and/or for repairs after the warranty period has expired. The Company repairs and calibrates a wide range of airborne navigation and communication equipment. Revenue is recognized at the time the repaired or calibrated unit is shipped back to the customer, as it is at this time that the work is completed.

*<u>Other</u>*

The majority of the Company's revenues are from contracts with the U.S. government, airlines, aircraft manufacturers, such as Boeing and Lockheed Martin, domestic distributors, international distributors for sales to military and commercial customers, and other commercial customers. The contracts with the U.S. government typically are subject to the Federal Acquisition Regulation ("FAR") which provides guidance on the types of costs that are allowable in establishing prices for goods and services provided under U.S. government contracts.

Payment terms and conditions vary by contract, although terms include a requirement of payment within a range from 30 to 60 days, or in certain cases, up-front deposits. In circumstances where the timing of revenue recognition differs from the timing of invoicing, the Company has determined that the Company's contracts do not include a significant financing component. Payments received prior to the delivery of units or services performed are recorded as deferred revenues. Taxes collected from customers, which are subsequently remitted to governmental authorities, are excluded from sales. The Company applied the practical expedient to account for shipping and handling activities as fulfillment cost rather than as a separate performance obligation. Shipping and handling costs charged to customers are classified as sales, and the shipping and handling costs incurred are included in cost of sales. All sales are denominated in U.S. dollars.

The Company chose to apply the available practical expedient as commission eligible sales orders are fulfilled within less than one year and commissions are generally paid by the Company within 30 days of the related sales order fulfillment. Accordingly, management has determined that no change in accounting for costs to obtain a contract will be required for the Company to conform to ASC 606.

*<u>Disaggregation of revenue</u>*

In the following tables, revenue is disaggregated by revenue category.

---

| | | |
|:---|:---|:---|
|  | **For the Three Months Ended** <br> **December 31, 2022** | **For the Three Months Ended** <br> **December 31, 2022** |
|  | **Commercial** | **Government** |
| **Sales Distribution**  |  |  |
| Test Units | $197681 | $1838697 |
|  | $197681 | $1838697 |

---

The remainder of our revenues for the three months ended December 31, 2022, are derived from repairs and calibration of $193,848, replacement parts of $50,078, extended warranties of $29,393 and other revenues of $18,557. We do not disaggregate these revenue streams as they are not deemed an important element related to how management operates the business between segments.

---

| | | |
|:---|:---|:---|
|  | **For the Three Months Ended** <br> **December 31, 2021** | **For the Three Months Ended** <br> **December 31, 2021** |
|  | **Commercial** | **Government** |
| **Sales Distribution**  |  |  |
| Test Units | $91688 | $2533296 |
|  | $91688 | $2533296 |

---

------

[**Table of Contents**](#toc)

**<u>TEL-INSTRUMENT ELECTRONICS CORP.</u>**

**<u>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</u>**

**(Unaudited)**

<u>Note 2</u> – <u>Summary of Significant Accounting Policies (continued)</u>

The remainder of our revenues for the three months ended December 31, 2021, are derived from repairs and calibration of $469,095, replacement parts of $37,186, extended warranties of $20,267 and other revenues of $20,000. We do not disaggregate these revenue streams as they are not deemed an important element related to how management operates the business between segments.

---

| | | |
|:---|:---|:---|
|  | **For the Nine Months Ended** <br> **December 31, 2022** | **For the Nine Months Ended** <br> **December 31, 2022** |
|  | **Commercial** | **Government** |
| **Sales Distribution**  |  |  |
| Test Units | $399613 | $4807723 |
|  | $399613 | $4807723 |

---

The remainder of our revenues for the nine months ended December 31, 2022, are derived from repairs and calibration of $1,124,213, replacement parts of $135,154, extended warranties of $86,797 and other revenues of $41,268. We do not disaggregate these revenue streams as they are not deemed an important element related to how management operates the business between segments.

---

| | | |
|:---|:---|:---|
|  | **For the Nine Months Ended** <br> **December 31, 2021** | **For the Nine Months Ended** <br> **December 31, 2021** |
|  | **Commercial** | **Government** |
| **Sales Distribution**  |  |  |
| Test Units | $269652 | $9012562 |
|  | $269652 | $9012562 |

---

The remainder of our revenues for the nine months ended December 31, 2021, are derived from repairs and calibration of $1,389,894, replacement parts of $170,430, extended warranties of $52,249 and other revenues of $20,000. We do not disaggregate these revenue streams as they are not deemed an important element related to how management operates the business between segments.

In the following table, revenue is disaggregated by geography.

---

| | | |
|:---|:---|:---|
|  | **For the Three Months** <br> **Ended** <br> **December 31, 2022** | **For the Three Months** <br> **Ended** <br> **December 31, 2021** |
| **Geography**  |  |  |
| United States | $1267013 | $1974538 |
| International | 1061241 | 1196994 |
| Total | $2328254 | $3171532 |

---

---

| | | |
|:---|:---|:---|
|  | **For the Nine Months** <br> **Ended** <br> **December 31, 2022** | **For the Nine Months** <br> **Ended** <br> **December 31, 2021** |
| **Geography**  |  |  |
| United States | $5252138 | $6885551 |
| International | 1342630 | 4029236 |
| Total | $6594768 | $10914787 |

---

For the three months ended December 31, 2022, three customers accounted for sales of $472,752 or 20%, $320,284 or 14%, and $239,100 or 10%. For the nine months ended December 31, 2022, three customers accounted for sales of $1,123,685 or 17%, $769,370 or 12% and $627,951 or 10%.

For the three months ended December 31, 2021, three customers accounted for sales of $673,758, $583,680 and $328,230 or 21%, 18% and 10% respectively. For the nine months ended December 31, 2021, four customers accounted for sales of $3,008,911, $1,585,620, $1,368,964 and $1,244,380 or 28%, 15%, 13% and 11% respectively.

------

[**Table of Contents**](#toc)

**<u>TEL-INSTRUMENT ELECTRONICS CORP.</u>**

**<u>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</u>**

**(Unaudited)**

<u>Note 2</u> – <u>Summary of Significant Accounting Policies (continued)</u>

The Company, in addition to inside sales efforts, utilizes independent sales agents to sell its products to customers. A related party independent sales agent earned $43,778 and $71,458 in commissions for the three and nine months ended December 31, 2022, respectively. The sales agent earned $9,000 and $27,000 for sales and marketing assistance for the three and nine months ended December 31, 2022. The same related party independent sales agent earned $13,000 and $94,000 in commissions for the three and nine months ended December 31, 2021, respectively. The sales agent earned $9,000 and $27,000 for sales and marketing assistance for the three and nine months ended December 31, 2021, respectively.

<u>Long-Lived Assets</u>

The Company assesses the recoverability of the carrying value of its long-lived assets whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future, undiscounted cash flows expected to be generated by an asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell. No impairment losses have been recognized for the three and nine months ended December 31, 2022 and 2021.

<u>New Accounting Pronouncements</u>

In June 2016, the FASB issued ASU No. 2016-13 Financial Instruments -Credit Losses (Topic 326), Measurement of Credit Losses on Financial Statements. The amendment in this update replaces the incurred loss impairment methodology in current GAAP with a methodology that reflects expected credit losses on instruments within its scope, including trade receivables. This update is intended to provide financial statement users with more decision-useful information about the expected credit losses. The effective date of the new standard has been deferred to April 1, 2023. We do not expect the adoption of this standard to have a significant impact on our financial position and results of operations.

No other recently issued accounting pronouncements had or are expected to have a material impact on the Company's unaudited condensed consolidated financial statements.

<u>Note 3</u> – <u>Accounts Receivable, net</u>

The following table sets forth the components of accounts receivable:

---

| | | |
|:---|:---|:---|
|  | **December 31,**<br> **2022** | **March 31,**<br> **2022** |
| Government | $898851 | $697731 |
| Commercial | 377903 | 358734 |
| Less: Allowance for doubtful accounts | (6401) | (7425) |
|  | $1270353 | $1049040 |

---

<u>Note 4</u> – <u>Restricted Cash to Support Appeal Bond</u>

In January 2018, the Company transferred $2,000,000 to a restricted cash account to secure a letter of credit which was used for collateral for the appeal bond (See Note 12).

<u>Note 5</u> – <u>Inventories, net</u>

Inventories consist of:

---

| | | |
|:---|:---|:---|
|  | **December 31,**<br> **2022** | **March 31,**<br> **2022** |
| Purchased parts | $2700756 | $2371105 |
| Work-in-process | 1097939 | 962460 |
| Finished Goods | 17464 |  |
| Less: Inventory reserve | (505000) | (513068) |
|  | $3311159 | $2820497 |

---

------

[**Table of Contents**](#toc)

**<u>TEL-INSTRUMENT ELECTRONICS CORP.</u>**

**<u>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</u>**

**(Unaudited)**

<u>Note 6</u> – <u>Prepaid expenses and other current assets</u>

Prepaid expenses and other current assets consist of:

---

| | | |
|:---|:---|:---|
|  | **December 31,**<br> **2022** | **March 31,**<br> **2022** |
| Prepaid expenses | $250918 | $181056 |
| Deferred charges | 24719 | 24204 |
| Other receivables | 691975 | 38780 |
|  | $967612 | $244040 |

---

In March 2020, the Coronavirus Aid, Relief, and Economic Security Act was signed into law, providing numerous tax provisions and other stimulus measures, including the Employee Retention Tax Credit ("ERTC"): a refundable tax credit against certain employment taxes. The Taxpayer Certainty and Disaster Tax Relief Act of 2020 and the American Rescue Plan Act of 2021 extended and expanded the availability of the ERTC. We qualified for the ERTC in the first two quarters of 2021. During the quarter ended December 31, 2022, we recorded an aggregate benefit of $628,401 in our financial statements and the receivable for the ERTC benefit as of December 31, 2022 is in Other current assets.

<u>Note 7</u> – <u>Net Income (Loss) per Share</u>

Net income (loss) per share has been computed according to Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC 260"), "Earnings per Share," which requires a dual presentation of basic and diluted income per share ("EPS"). Basic EPS represents net income (loss) divided by the weighted average number of common shares outstanding during a reporting period. Diluted EPS reflects the potential dilution that could occur if securities, including preferred stock, warrants and options, were converted into common stock. The dilutive effect of outstanding warrants and options is reflected in earnings per share by use of the treasury stock method. The dilutive effect of preferred stock is reflected in earnings per share by use of the if-converted method. In applying the treasury stock method for stock-based compensation arrangements, the assumed proceeds are computed as the sum of the amount the employee must pay upon exercise and the amounts of average unrecognized compensation. For the nine months ended December 31, 2022, since the Company has a net loss, the effect of common stock equivalents is anti-dilutive, and as such, common stock equivalents have been excluded from this calculation.

---

| | | |
|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** |
|  | **December 31, 2022** | **December 31, 2021** |
| **Basic net income (loss) per share computation:** |  |  |
| Net income | $392627 | $194622 |
| Less: Preferred dividends | (80000) | (80000) |
| Net income attributable to common shareholders | 312627 | 114622 |
| Weighted-average common shares outstanding | 3255887 | 3255887 |
| Basic net income per share | $0.10 | $0.04 |
| **Diluted net income per share computation** |  |  |
| Net income attributable to common shareholders | $312627 | $114622 |
| Add: Preferred dividends | 80000 | 80000 |
| Diluted Net income attributable to common shareholders | $392627 | $194622 |
| Weighted-average common shares outstanding | 3255887 | 3255887 |
| Incremental shares attributable to the assumed conversion of <br> preferred stock | 1899778 | 1839778 |
| Total adjusted weighted-average shares | 5155665 | 5095665 |
| Diluted net income per share | $0.08 | $0.04 |

---

------

[**Table of Contents**](#toc)

**<u>TEL-INSTRUMENT ELECTRONICS CORP.</u>**

**<u>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</u>**

**(Unaudited)**

<u>Note 7</u> – <u>Net Income (Loss) per Share (continued)</u>

---

| | | |
|:---|:---|:---|
|  | **Nine Months Ended** | **Nine Months Ended** |
|  | **December 31, 2022** | **December 31, 2021** |
| **Basic net (loss) income per share computation:** |  |  |
| Net (loss) income | $(317610) | $1769799 |
| Less: Preferred dividends | (240000) | (240000) |
| Net (loss) income attributable to common shareholders | (557610) | 1529799 |
| Weighted-average common shares outstanding | 3255887 | 3255887 |
| Basic net (loss) income per share | $(0.17) | $0.47 |
| **Diluted net (loss) income per share computation** |  |  |
| Net (loss) income attributable to common shareholders | $(557610) | $1529799 |
| Add: Preferred dividends |  | 240000 |
| Net (loss) income attributable to common shareholders | $(557610) | $1769799 |
| Weighted-average common shares outstanding | 3255887 | 3255887 |
| Incremental shares attributable to the assumed conversion of <br> preferred stock |  | 1839778 |
| Total adjusted weighted-average shares | 3255887 | 5095665 |
| Diluted net (loss) income per share | $(0.17) | $0.35 |

---

The following table summarizes securities that, if exercised, would have an anti-dilutive effect on earnings per share for the three months ended:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **December 31, 2022** | **December 31, 2022** | **December 31, 2021** | **December 31, 2021** |
| Stock options |  | 111500 |  | 121500 |
|  |  | 111500 |  | 121500 |

---

The following table summarizes securities that, if exercised, would have an anti-dilutive effect on earnings per share for the nine months

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **December 31, 2022** | **December 31, 2022** | **December 31, 2021** | **December 31, 2021** |
| Convertible preferred stock |  | 1899778 |  |  |
| Stock options |  | 111500 |  | 121500 |
|  |  | 2011278 |  | 121500 |

---

<u>Note 8</u> – <u>Line of Credit</u>

The Company has a line of credit with Bank of America with open availability up to $690,000. The borrowing base calculation is tied to accounts receivable and is collateralized by substantially all of the assets of the Company. Interest on any outstanding balance is payable monthly at an annual interest rate equal to the LIBOR (London Interbank Offered Rates) daily float plus 3.75 percentage points. On July 29, 2022, Bank of America extended the maturity date of the line of credit from July 30, 2022 to July 30, 2023.

As of December 31, 2022 and March 31, 2022 the line of credit draw remained at zero balance.

------

[**Table of Contents**](#toc)

**<u>TEL-INSTRUMENT ELECTRONICS CORP.</u>**

**<u>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</u>**

**(Unaudited)**

<u>Note 9</u> – <u>Segment Information</u>

In accordance with FASB ASC 280, "Disclosures about Segments of an Enterprise and related information", the Company determined it has two reportable segments - avionics government and avionics commercial. There are no inter-segment revenues.

The Company is organized primarily on the basis of its avionics products. The avionics government segment consists primarily of the design, manufacture, and sale of test equipment to the U.S. and foreign governments and militaries either directly or through distributors. The avionics commercial segment consists of design, manufacture, and sale of test equipment to domestic and foreign airlines, directly or through commercial distributors, and to general aviation repair and maintenance shops. The Company develops and designs test equipment for the avionics industry and as such, the Company's products and designs cross segments.

Management evaluates the performance of its segments and allocates resources to them based on gross margin. The Company's general and administrative costs and sales and marketing expenses, and engineering costs are not segment specific. As a result, all operating expenses are not managed on a segment basis. Net interest includes expenses on debt and income earned on cash balances, both maintained at the corporate level.

The tables below present information about reportable segments within the avionics business for the three and nine months ending December 31, 2022, and 2021:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Three Months Ended**<br> **December 31, 2022** | **Avionics**<br> **Government** | **Avionics**<br> **Commercial** | **Avionics**<br> **Total** | **Corporate**<br> **Items** | **Total** |
| Net sales | $1838697 | $489557 | $2328254 | $- | $2328254 |
| Cost of sales | 1041984 | 392563 | 1434547 |  | 1434547 |
| Gross margin | 796713 | 96994 | 893707 |  | 893707 |
| Total expenses (income) |  |  | 571421 | (174737) | 396684 |
| Income before income taxes |  |  | $322286 | $174737 | $497023 |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Three Months Ended**<br> **December 31, 2021** | **Avionics**<br> **Government** | **Avionics**<br> **Commercial** | **Avionics**<br> **Total** | **Corporate**<br> **Items** | **Total** |
| Net sales | $2552546 | $618986 | $3171532 | $- | $3171532 |
| Cost of sales | 1366699 | 397040 | 1763739 |  | 1763739 |
| Gross margin | 1185847 | 221946 | 1407793 |  | 1407793 |
| Total expenses |  |  | 761250 | 405473 | 1166723 |
| Income (loss) before income taxes |  |  | $646543 | $(405473) | $241070 |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Nine Months Ended**<br> **December 31, 2022** | **Avionics**<br> **Government** | **Avionics**<br> **Commercial** | **Avionics**<br> **Total** | **Corporate**<br> **Items** | **Total** |
| Net sales | $4807723 | $1787045 | $6594768 | $- | $6594768 |
| Cost of sales | 2971200 | 1341205 | 4312405 |  | 4312405 |
| Gross margin | 1836523 | 445840 | 2282363 |  | 2282363 |
| Total expenses |  |  | 2042165 | 642257 | 2684422 |
| Loss (income) before income taxes |  |  | $240198 | $(642257) | $(402059) |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Nine Months Ended** <br> **December 31, 2021** | **Avionics**<br> **Government** | **Avionics** <br> **Commercial** | **Avionics**<br> **Total** | **Corporate**<br> **Items** | **Total** |
| Net sales | $9031812 | $1882975 | $10914787 | $- | $10914787 |
| Cost of sales | 4627834 | 1196507 | 5824341 |  | 5824341 |
| Gross margin | 4403978 | 686468 | 5090446 |  | 5090446 |
| Total expenses |  |  | 2539621 | 502580 | 3042201 |
| Income (loss) before income taxes |  |  | $2550825 | $(502580) | $2048245 |

---

------

[**Table of Contents**](#toc)

**<u>TEL-INSTRUMENT ELECTRONICS CORP.</u>**

**<u>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</u>**

**(Unaudited)**

<u>Note 10</u> – <u>Income Taxes</u>

FASB ASC 740-10, "Accounting for Uncertainty in Income Taxes" ("ASC 740-10") prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The Company has analyzed filing positions in all of the federal and state jurisdictions where it is required to file income tax returns, as well as all open tax years in these jurisdictions. The Company does not have any unrecognized tax benefits.

The tax effect of temporary differences, primarily net operating loss carryforwards, asset reserves and accrued liabilities, gave rise to the Company's deferred tax asset. Deferred income taxes are recognized for the tax consequence of such temporary differences at the enacted tax rate expected to be in effect when the differences reverse. The Company had approximately $2.6 million in deferred tax assets at December 31, 2022 and approximately $2.5 million in deferred tax assets at March 31, 2022. The Company recognizes the impact of an uncertain income tax position taken on its income tax return at the largest amount that is more-likely-than-not to be sustained upon audit by the relevant taxing authority.

The net income was $392,627 for the three months ended December 31, 2022, which resulted in a net loss improvement or a net loss of $317,610 for the nine months ended December 31, 2022. This resulted in an adjusted NOL income tax benefit of $84,449 for the nine months ended December 31, 2022.

<u>Note 11</u> – <u>Operating Lease Liability</u>

The Company leases its facility in East Rutherford, NJ with monthly payments of $21,237 until August 2025. Thereafter, monthly payments are $23,083 for the balance of the 8 year lease agreement expiring August 2029.

The Company's leases generally do not provide an implicit rate, and therefore the Company uses its incremental borrowing rate as the discount rate when measuring operating lease liabilities. The incremental borrowing rate represents an estimate of the interest rate the Company would incur at lease commencement to borrow an amount equal to the lease payments on a collateralized basis over the term of a lease. The Company estimated its incremental borrowing rate based on its credit quality, line of credit agreement and by comparing interest rates available in the market for similar borrowings. The Company used a discount rate of 3.90% for both December 31, 2022 and March 31, 2022, respectively.

The following table reconciles the undiscounted future minimum lease payments (displayed by year and in the aggregate) under non-cancelable operating leases with terms of more than one year to the total lease liabilities recognized on the unaudited condensed consolidated balance sheet as of December 31, 2022:

---

| | |
|:---|:---|
| Remaining payments 2023 | $63710 |
| 2024 | 254840 |
| 2025 | 254840 |
| 2026 | 267767 |
| 2027 | 277000 |
| Thereafter | 669416 |
| Total undiscounted future minimum lease payments | 1787573 |
| Less: Difference between undiscounted lease payments and discounted lease liabilities | (212196) |
| Present value of net minimum lease payments | 1575377 |
| Less current portion | (200148) |
| Operating lease liabilities – long-term | $1375229 |

---

Total rent expense for the three and nine months ended December 31, 2022, was $96,233 and $304,736, respectively, as compared to $100,967 and $288,117 for the three and nine months ended December 31, 2021, respectively.

------

[**Table of Contents**](#toc)

**<u>TEL-INSTRUMENT ELECTRONICS CORP.</u>**

**<u>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</u>**

**(Unaudited)**

<u>Note 12</u> – <u>Litigation</u>

Contingencies are recorded in the consolidated financial statements when it is probable that a liability will be incurred and the amount of the loss is reasonably estimable, or otherwise disclosed, in accordance with Accounting Standards Codification 450, Contingencies (ASC 450). Significant judgment is required in both the determination of probability and the determination as to whether a loss is reasonably estimable. In the event the Company determines that a loss is not probable, but is reasonably possible, and it becomes possible to develop what the Company believes to be a reasonable range of possible loss, then the Company will include disclosures related to such matter as appropriate and in compliance with ASC 450. To the extent there is a reasonable possibility that the losses could exceed the amounts already accrued, the Company will, when applicable, adjust the accrual in the period the determination is made, disclose an estimate of the additional loss or range of loss or if the amount of such adjustment cannot be reasonably estimated, disclose that an estimate cannot be made. On March 24, 2009, Aeroflex Wichita, Inc. ("Aeroflex") filed a petition against the Company and two of its employees in the District Court located in Sedgwick County, Kansas, Case No. 09 CV 1141 (the "Aeroflex Action"), alleging that the Company and its two employees misappropriated Aeroflex's proprietary technology in connection with the Company winning a substantial contract from the U.S. Army, to develop new Mode-5 radar test sets and kits to upgrade the existing TS-4530 radar test sets to Mode 5 (the "Award"). Aeroflex's petition, seeking injunctive relief and damages, alleges that in connection with the Award, the Company and its named employees misappropriated Aeroflex's trade secrets; tortiously interfered with Aeroflex's business relationship; conspired to harm Aeroflex and tortiously interfered with Aeroflex's contract. The central basis of all the claims in the Aeroflex Action is that the Company misappropriated and used Aeroflex proprietary technology and confidential information in winning the Award. In February 2009, subsequent to the Company winning the Award, Aeroflex filed a protest of the Award with the Government Accounting Office ("GAO"). In its protest, Aeroflex alleged, inter alia, that the Company used Aeroflex's proprietary technology in order to win the Award, the same material allegations as were later alleged in the Aeroflex Action. On or about March 17, 2009, the U.S. Army Contracts Attorney, and the U.S. Army Contracting Officer each filed a statement with the GAO, expressly rejecting Aeroflex's allegations that the Company used or infringed on Aeroflex's proprietary technology in winning the Award and concluding that the Company had used only its own proprietary technology. On April 6, 2009, Aeroflex withdrew its protest.

In December 2009, the Kansas District Court dismissed the Aeroflex Action on jurisdiction grounds. Aeroflex appealed this decision. In May 2012, the Kansas Supreme Court reversed the decision and remanded the Aeroflex Action to the Kansas District Court for further proceedings. The case then entered an extended discovery period in the District Court.

On May 23, 2016, the Company filed a motion for summary judgment based on Aeroflex's lack of jurisdictional standing to bring the case. The motion asserts that Aeroflex does not own the intellectual property at issue since it is a bare licensee of Northrop Grumman. Northrop Grumman has declined to join this suit as plaintiff. The motion asserted Aeroflex lacks standing to sue alone. Also, the motion raises the fact that Aeroflex allowed the license to expire, Aeroflex's claims are either moot or Aeroflex lacks standing to sue for damages alleged to have accrued after the license ended in 2011. The motion for summary judgment was denied.

The Aeroflex trial on remand in the Kansas District Court began in March 2017. After a nine-week trial, the jury rendered its verdict. The jury found no misappropriation of Aeroflex trade secrets, but it did rule that the Company tortiously interfered with a prospective business opportunity and awarded damages of $1.3 million for lost profits. The jury also ruled that Tel tortiously interfered with Aeroflex's non-disclosure agreements with two former Aeroflex employees and awarded damages of $1.5 million for lost profits, resulting in total damages against the Company of $2.8 million. The jury also found that the former Aeroflex employees breached their non-disclosure agreements with Aeroflex and awarded damages against these two individuals totaling $525,000. The jury also decided that punitive damages should be allowed against the Company.

Following the verdict, the Company filed a motion for judgment as a matter of law. In the motion, the Company renewed its motion for judgment on Aeroflex's tortious interference with prospective business opportunity claim arguing that such claim is barred by the statute of limitations. Alternatively, the motion asserts there is insufficient evidence supporting the lost profit award on that claim. Additionally, the motion for judgment addresses inconsistency between the awards against the former Aeroflex employees for breach of the non-disclosure agreements and the award against the Company for interfering with those agreements. Alternatively, the motion asserts there is insufficient evidence supporting the lost profit award on that claim.

During July 2017, the Court heard the Company's motion for judgment as well as conducting a hearing as to the amount of a punitive damages award. Kansas statutes limit punitive damages to a maximum of $5 million.

Aeroflex submitted a motion to the Court requesting that the judge award punitive damages at the maximum $5 million amount. In October 2017, the Court denied the Company's motions and awarded Aeroflex an additional $2.1 million of punitive damages, which brings the total Tel damages awarded in this case to approximately $4.9 million.

------

[**Table of Contents**](#toc)

**<u>TEL-INSTRUMENT ELECTRONICS CORP.</u>**

**<u>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</u>**

**(Unaudited)**

<u>Note 12</u> – <u>Litigation (continued)</u>

The journal entry of judgment including judgment against the Company in the amount of $1.3 million for tortious interference with prospective business advantage, of $1.5 million for tortious interference with existing contracts, and $2.1 million in punitive damages was entered on November 22, 2017. Pursuant to K.S.A. 16-204(d) "any judgment rendered by a court of this state on or after July 1, 1986, shall bear interest on and after the day on which judgment is rendered at the rate provided by subsection (e). The Kansas Secretary of State publishes the rate amount. The amount published for July 1, 2017, through June 30, 2018, was 5.75%, 6.5% July 1, 2018, through June 30, 2019, 7.0% July 1, 2019, through June 30, 2020, and 4.25% July 1, 2020 through June 30, 2022. The interest rate through December 31, 2022 was 5.75%. Interest on the $4,900,000 judgment started to accrue on November 22, 2017, the date the judgment was entered. As of December 31, 2022, the outstanding amount of the judgement and accrued interest is $6,291,226.

The Company filed post-trial motions to avoid damage duplication and inconsistency, and to secure judgment as a matter of law or a new trial. The trial court denied those motions. The Company appealed the verdict and the post-trial rulings to the Court of Appeals of the State of Kansas, Case No. 18-119,563. The Company posted a $2 million supersedeas bond. The Plaintiff filed a cross-appeal. The appeal and cross-appeal are fully briefed. The appellate court has not set a date to hear the appeal.

The Company is very optimistic about the prospects of its appeal for a judgment as a matter of law. The Company was hoping for a decision from the court in calendar year 2022, but this timing was likely delayed due to the three month COVID-19 related shutdown of the Kansas court system. The appeal decision has been delayed due to the COVID-19 related shutdown of the Kansas court system and the inability of court staff to work remotely on confidentiality issues. During August 2021, in an effort to move the appeal forward, all parties agreed to supply the appeal information to the court on a dedicated and secured laptop that would be used by the research attorney remotely. The Company has the ability to settle this case at its sole discretion by withdrawing the appeal and paying the judgment plus interest amount. The Company currently has sufficient cash on hand to pay off this liability if the appeal is lost.

On January 28, 2022, Aeroflex filed a Motion to Require Supplemental Appeal Bond with the Court of Appeals of the State of Kansas, seeking a bond from the Company in the amount of $6 million to supplement the existing bond of $2 million. The Company has filed a response and we are confident that this motion will be denied.

On October 14, 2022, the Company received an order from the Kansas appellate court of appeals lifting the briefing stay that was entered on March 19, 2020. The Kansas appellate court has notified the Company that the argument has been set for hearing on March 30, 2023 in Topeka, Kansas. A decision on the case is expected approximately 90 days after the conclusion of the arguments.

Other than the matters outlined above, we are currently not involved in any litigation that we believe could have a material adverse effect on our financial condition or results of operations. There is no action, suit, proceeding, inquiry, or investigation before any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of executive officers of our

Company, threatened against or affecting our Company, or our common stock in which an adverse decision could have a material effect.

------

[**Table of Contents**](#toc)

**<u>TEL-INSTRUMENT ELECTRONICS CORP.</u>**

**<u>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</u>**

**(Unaudited)**

<u>Note 13</u> – <u>Stock Options</u>

The Board of Directors (the "Board") adopted on January 18, 2017, and ratified by the shareholders at the Annual Meeting on January 18, 2017, the Company's 2016 Stock Option Plan (the "Plan"). The Plan provides for the granting of incentive stock options, by a committee to be appointed by the Board (both the Board and the Committee are referred to herein as the "Committee") to directors, officers, and employees (excluding directors and officers who are not employees) to purchase shares of the Common Stock of the Company, par value $0.10 per share (the "Stock"), in accordance with the terms and provisions. The 2016 Plan reserves for issuance, options to purchase up to 250,000 shares of its common stock. Options granted under the plan are exercisable up to a period of five years from the date of grant at an exercise price which is not less than the fair market value of the common stock at the date of grant, except to a shareholder owning 10% or more of the outstanding common stock of the Company, as to which the exercise price must be not less than 110% of the fair market value of the common stock at the date of grant. Options are exercisable on a cumulative basis, 20% at or after each of the first, second, and third anniversary of the grant and 40% after the fourth year anniversary.

A summary of the status of the Company's stock option plans for the fiscal year ended March 31, 2022, and year to date December 31, 2022, and changes during the year are presented below (in number of options):

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Number of** <br> **Options** | **Average** <br> **Exercise Price** | **Average Remaining**<br> **Contractual Term** | **Aggregate** <br> **Intrinsic Value** |
| Outstanding options at April 1, 2022 | 111500 | $3.14 | 2.72 years | $3680 |
| Options granted |  | $- |  |  |
| Options exercised |  | $- |  |  |
| Options canceled/forfeited |  | $- |  |  |
| Outstanding options at December 31, 2022 | 111500 | $3.14 | 1.97 years | $- |
| Vested Options: |  |  |  |  |
| December 31, 2022: | 54700 | $3.18 | 1.5 years | $- |

---

Remaining options available for grant were 138,500 as of December 31, 2022.

At December 2022, the unamortized compensation expense for stock options was $27,222. Unamortized compensation expense is expected to be recognized over a weighted-average period of approximately 2.4 years.

For the three months ended December 31, 2022, the Company recorded stock compensation costs of $6,234, as compared to $7,514 for the three months ended December 31, 2021. The Company recorded stock compensation costs of $18,703 as compared to $19,848 for the nine months ended December 31, 2021.

------

[**Table of Contents**](#toc)

**Item 2. Management**'**s Discussion and Analysis of Financial Condition and Results of Operations**

**<u>Forward Looking Statements</u>**

This Quarterly Report on Form 10-Q and other reports filed by the Company from time to time with the SEC (collectively the "Filings") contain or may contain forward-looking statements and information that are based upon beliefs of, and information currently available to, the Company's management as well as estimates and assumptions made by Company's management. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. When used in the Filings, the words "may," "will," "anticipate," "believe," "estimate," "expect," "future," "intend," "plan," or the negative of these terms and similar expressions as they relate to the Company or the Company's management are intended to identify forward-looking statements. Such statements reflect the current view of the Company with respect to future events and we caution you that these statements are not guarantees of future performance or events and are subject to risks, assumptions, and other factors. Should one or more of these risks or uncertainties materialize, or should the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended, or planned.

The key factors that are not within the Company's control and that may have a direct bearing on operating results include, but are not limited to, managements' ability to raise capital in the future, the retention of key employees and changes in the regulation of our industry, as well as the risk factors identified in the Company's filings.

Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee future results, levels of activity, performance, or achievements. Except as required by applicable law, including the securities laws of the United States, the Company does not intend to update any of the forward-looking statements to conform these statements to actual results.

Our unaudited condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States ("GAAP"). These accounting principles require us to make certain estimates, judgments, and assumptions. We believe that the estimates, judgments, and assumptions upon which we rely are reasonable based upon information available to us at the time that these estimates, judgments, and assumptions are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities as of the date of the financial statements as well as the reported amounts of revenues and expenses during the periods presented. Our unaudited condensed consolidated financial statements would be affected to the extent there are material differences between these estimates and actual results. In many cases, the accounting treatment of a particular transaction is specifically dictated by GAAP and does not require management's judgment in its application. There are also areas in which management's judgment in selecting any available alternative would not produce a materially different result. The following discussion should be read in conjunction with our financial statements and notes thereto appearing elsewhere in this report.

For purposes of this Quarterly Report, "Tel-Instrument," "we," "our," "us," or similar references refers to Tel-Instrument Electronics, Inc, unless the context requires otherwise.

**<u>Overview</u>**

The Company reported net sales of $2,328,254 and $6,594,768 for the three and nine months ended December 31, 2022. This compared to net sales of $3,171,532 and $10,914,787 for the same three and nine-month period in the prior fiscal year. The sharp decline in sales for the first nine months of the current fiscal year was primarily caused by supply chain procurement issues and unanticipated delays in securing certain high dollar contracts. Long supplier lead times for certain high demand chips have been unprecedented, preventing the timely production of finished units being shipped to customers. The supply chain situation is gradually improving, and TIC has received sufficient parts to increase production operations during the fourth quarter of the current fiscal year.

The gradual improvement in parts receipts resulted in a net loss from operations of $66,025 for the third quarter. The net loss from operations for the first nine months of the fiscal year was $845,294. Gross margin for the current quarter was $893,707 (38.4%) which is approximately 6% lower than the three months ended December 31, 2021 of $1,407,793 (44.4%). This is primarily attributable to fixed production costs being spread over much lower volumes.

Net income was $392,627 and net loss was $317,610 for the three and nine months ended December 31, 2022, respectively. The current quarter ended December 31, 2022 was positively impacted by $628,400 of Employee Retention Tax Credit ("ERC") filings.

------

[**Table of Contents**](#toc)

*Overview (continued)*

Backlog orders on December 31, 2022, were $5.6 million compared to $3.5 million as of March 31, 2022. The increase was primarily due to the $2.9 million Navy contract to upgrade the CRAFT test set. This work will be completed over the next two years and should result in significant production revenues when the development work is completed. The Critical Design Review ("CDR") for this program is scheduled for April 2023 and will generate approximately $700K of NRE ("non-recurring engineering") billings.

The Company continues to pursue opportunities in the domestic and international market for our Mode 5 test sets. The international market has been slow over the last year due in part to the recent strength of the dollar. We are still expecting a large follow-on order from the German government within the next six months. We continue to receive orders from the U.S. Government and Lockheed Martin for our AN/USM-708 and 719 ("CRAFT") Mode 5 test sets. TIC expects to receive a $1.6 million order for the F-35 program in February 2023. Our expectation is that orders and back-log will improve this fiscal year as the SDR/OMNI test set enters the marketplace. We are also in negotiations with the U.S. Army on a funded software upgrade to the TS-4530A product which should be very profitable as the engineering work has already largely been completed.

TIC is also exploring new avenues to broaden its product portfolio including designing a high frequency test set for the Lockheed Martin F-35 program. This contract takes advantage of our expertise in RF technology. This is a completely new market for TIC as it involves high frequency communication signals. This contract includes non-recurring engineering funding and expected annual production revenues in the $600,000 to $700,000 range. TIC has successfully completed the engineering portion of the program and is waiting for a production order. TIC will continue to explore funded engineering programs of this nature as this is high margin business that helps diversify and expand our product portfolio.

The main focus area for the Company is moving into the secure communications testing. The key for long-term sustained growth will be to supplement our strong position in military Mode 5 transponder testing with dominant product offerings in the much larger commercial and military communications and navigation test set market. TIC has spent several years and millions of dollars in developing our ground-breaking SDR/OMNI product which is meant to address both the commercial market for transponder and navigation test sets as well as competing in the military secure comm test set market. The SDR/OMNI supports a wide frequency range to accommodate new commercial and military waveforms in an industry leading 4-pound package. This is approximately half the weight of competitive test sets. It is also the only new multi-purpose test set which meets the Class 1 military environmental specifications. It utilizes the latest touch screen technology and has the capability to replace all TIC commercial test sets and military flight-line test sets with one handheld product. TIC is in the process of demonstrating this product to customers and finalizing product verification. The Company has started initial production deliveries in December 2022 and has sold over $250,000 of SDR/OMNI test sets in January 2023. There are several companies competing in this market space, but we believe that our SDR/OMNI design will be extremely competitive, particularly for military applications.

The Aeroflex litigation did not result in a favorable outcome for the Company, despite our belief that we committed no wrongdoing. The jury found no misappropriation of Aeroflex trade secrets, but it did rule that the Company tortiously interfered with a prospective business opportunity and awarded damages. The jury also ruled that Tel tortiously interfered with Aeroflex's non-disclosure agreements with two former Aeroflex employees. The jury also found that the former Aeroflex employees breached their non-disclosure agreements with Aeroflex. The Court conducted further hearings on the Company's post-trial motions which sought to reduce the damages award of $2.8 million, as well as the punitive damages claim. The Court denied the Company's motions and awarded Aeroflex an additional $2.1 million of punitive damages. The Company has filed motions in January 2018 for the Court to reconsider the number of damages on the grounds that they are duplicative and not legally supportable. The Court heard these motions, and such motions were denied. The Company filed for an appeal during 2019. The Company has posted a $2 million bond for the appeal. This $2 million bond amount will remain in place during the appeal process. The appeal process has effectively been in limbo for several years due to the Kansas Supreme Court moving to remote work until October 14, 2022, when the Company received an order from the Kansas appellate court of appeals lifting the briefing stay that was entered on March 19, 2020. The Kansas appellate court has notified the Company that the argument has been set for hearing on March 30, 2023 in Topeka, Kansas. A decision on the case is expected approximately 90 days after the conclusion of the arguments.

We believe we have strong appeal grounds, and the plan is to wait for the eventual decision despite the negative impact of the interest accruals on our financial results. The best case scenario is that the award is vacated while the worst-case scenario would be a dismissal which would require TIC to pay the judgement amount plus accrued interest. TIC's cash and borrowing position should allow for the payment of the entire amount if necessary. This is based on expected improved first quarter results and receipt of the Navy CDR NRE funding.

------

[**Table of Contents**](#toc)

**<u>Results of Operations</u>**

**<u>Sales</u>**

Net sales were $2,328,254 and $6,594,768 for the three and nine months ended December 31, 2022, as compared to $3,171,532 and $10,914,787 for the same three and nine month period in the prior fiscal year, respectively. The decrease in sales of $843,278 (27%) and $4,320,019 (40%) respectively, was due primarily to supply chain issues, where supplier lead times have increased from several months to over six months in some cases. In particular, chip components have been especially difficult to receive on a timely basis by our printed circuit board ("PCB") vendors.

**<u>Gross Margin</u>**

Gross margin for the current quarter was $893,707 (38.4%) which is approximately 6% lower than the three months ended December 31, 2021 of $1,407,793 (44.4%). This is primarily attributable to fixed production costs being spread over much lower volumes plus higher parts component costs for hard to find obsolete parts. TIC has increased its selling prices during January 2023 to offset these added costs.

For the nine months ended December 31, 2022, total gross margin decreased to $2,282,363 as compared to $5,090,446 for the nine months ended December 31, 2021.

**<u>Operating Expenses</u>**

Selling, general and administrative expenses increased $54,111 (10%) to $578,077 and decreased $61,597 (4%) to $1,613,021 for the three and nine months ended December 31, 2022 respectively, as compared to $523,966 and $1,674,618, respectively for the three and nine months ended December 31, 2021. The three month increase of $54,111 is primarily a result of a $63,308 accrual for a Homeland Security Investigations ("HIS") agency "Notice of Intent to Fine", as a result of a Form I-9 audit that was initiated March 2018 and the final fine amount settled during January 2023. The nine month decrease of $61,597 is a result of net lower sales commissions, consultant fees, and profit sharing accruals, partly offset by the resumption of travel and trade show participation.

Aeroflex litigation costs were $10,860 for the three months ended December 31, 2022, as compared to $17,145 for the three months ended December 31, 2021. Litigation costs decreased $9,443 to $12,102 for the nine months ended December 31, 2022, as compared to $21,545 for the nine months ended December 31, 2021. This is a direct result of decreased activity related to the litigation (see Notes 4 and 12 to the unaudited condensed consolidated financial statements) during the comparative time frame . With respect to the Aeroflex litigation, the Company has appealed the $4.9 million judgement and has set aside $2 million in cash to support an appeal bond. The appeal submissions are now complete. We continue to believe that the trial judge erred in his legal ruling on standing and other issues during the trial and that we have strong grounds for the award to be vacated or reduced. The Company has received an order that oral arguments for the appeal will take place on March 30, 2023.

Engineering, research, and development expenses decreased $203,323 (35%) to $370,795 and $448,011 or (23%) to $1,502,534 for the three and nine months ended December 31, 2022 respectively, as compared to $574,118 and $1,950,545 for the three and nine months ended December 31, 2021, respectively. Total engineering expense decreased primarily as a result of the restart of the Lockheed Martin MADL program and the Navy ECP Contract non-recurring engineering expenditures ("NRE") which reduced engineering costs in the current quarter by $160,184 and $344,276 for the nine months ended December 31, 2022, with the balance of the decrease a result of cost efficiencies.

**<u>(Loss) Income from Operations</u>**

As a result of the above, the Company recorded a loss from operations of $66,025 and $845,294 for the three and nine months ended December 31, 2022, as compared to income from operations of $292,564 and $1,443,738 for the three and nine months ended December 31, 2021.

**<u>Other Income (Expense), Net</u>**

For the three and nine months ended December 31, 2022, total other net income was $563,048 and $443,235, this is primarily a result of $628,400 of Employee Retention Tax Credits ("ERC") the Company was eligible for and has filed the required amended tax returns. The credit refunds are anticipated to be released by the Internal Revenue Service sometime between August – December 2023.

As compared to other net (expense) income of ($51,494) and $604,507 for the three and nine months ended December 31, 2021, primarily the result of the Second Draw PPP loan in the amount of $722,577 being fully forgiven on September 17, 2021 and on August 24, 2021, TIC, and the New Jersey Economic Development Authority (NJEDA) signed a small business emergency assistance grant agreement in the amount of $20,000.

------

[**Table of Contents**](#toc)

**<u>Income before Income Taxes</u>**

The Company recorded income before taxes of $497,023 and a net loss before taxes of $402,059 for the three and nine months ended December 31, 2022, as compared to income before taxes of $241,070 and $2,048,245 for the three and nine months ended December 31, 2021.

**<u>Income Tax (Benefit) Expense</u>**

For the three months ended December 31, 2022, the Company recorded a year to date adjusting income tax expense of $104,396. For the nine months ended December 31, 2022 recorded a tax benefit of $84,449, and related increase in its deferred tax asset, as a result of the Company's net loss, as compared to an income tax expense of $46,448 and $278,446 for the three and nine months ended December 31, 2021, respectively. The differences between income taxes, in the prior year, expected at the U.S. federal statutory income tax rate of 21 percent and the reported income tax expense are due to the recognition of non-taxable PPP funds of $722,577 as other income during the three months ended September 30, 2021.

**<u>Net Income (Loss)</u>**

The Company recorded net income of $392,627 and a net loss of $317,610 for the three and nine months ended December 31, 2022, as compared to net income of $194,622 and $1,769,799 for the three and nine months ended December 31, 2021.

**<u>Liquidity and Capital Resources</u>**

At December 31, 2022, the Company had net working capital of $3,142,693 including accrued legal damages related to the Aeroflex litigation of $6,291,226, as compared to working capital of $3,671,667 at March 31, 2022. This change is due primarily to the decline in sales revenue and profitability. During the nine months ended December 31, 2022, the Company's cash balance (including the $2 million in restricted cash for the appeal) decreased by approximately $1.7 million to $5,303,597. The Company's principal sources, and uses of funds were as follows:

*Cash (used in) provided by operating activities.* For the nine months ended December 31, 2022, $1,571,007 in cash from operations was used, as compared to the nine months ended December 31, 2021, the Company provided $2,048,312. This decrease in cash provided for operations is mostly attributed to the net loss for the nine months ended December 31, 2022, an increase in accounts receivable, and an increase in inventories as we build stock for production. In addition to buying additional inventory to address the supply chain interruptions, the Company has purchased a significant amount of inventory for the SDR/OMNI program. Additionally, the increase in other assets includes a receivable of $628,400 for Employee Retention Tax Credits ("ERC") as result of amended 941 federal form filings.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

*Cash used in investing activities*. For the nine months ended December 31, 2022, the Company used $6,136 for purchases of equipment as compared to the nine months ended December 31, 2021, the Company used $4,777.

*Cash (used in) financing activities.* For the nine months ended December 31, 2022, the Company used $80,000 in cash from financing activities as compared to $240,000 for the nine months ended December 31, 2021. This decrease is due to dividend payments of $80,000 per quarter not being made for quarter two and three.

The Bank of America line of credit was renewed and will mature July 30, 2023. As of December 31, 2022, the line of credit draw remained at zero.

On December 31, 2022, the Company had approximately $5.3 million of cash on hand which included $2 million of restricted cash supporting the appeal bond.

As of December 31, 2022, the Company has recorded total damages of $6,291,226 including accrued interest, as a result of the jury verdict associated with the Aeroflex litigation as well as the Court's decision on punitive damages. The Company has recorded accrued interest of $1,391,225 as of December 31, 2022.

The Company is very optimistic about the prospects of its appeal for a judgment as a matter of law. The appeal is scheduled to be heard on March 30, 2023 and a final decision is expected this summer. TIC's cash and borrowing position should allow for the payment of the entire amount if necessary. This is based on expected improved fourth quarter results and receipt of the $700K 0 Navy CDR NRE funding.

------

[**Table of Contents**](#toc)

Moving forward, we believe that our expected cash flows from operations and current cash balances, which amounted to approximately $5.3 million, including approximately $2 million in restricted cash will be sufficient to operate in the normal course of business for next 12 months from the issuance date of these unaudited condensed financial statements, including any payments for settlement of the litigation.

Currently, the Company has no material future capital expenditure requirements.

These unaudited condensed consolidated financial statements should be read in conjunction with the Company's Annual Report on For 10-K for the fiscal year ended March 31, 2022, filed with the SEC on June 17, 2022 (the "Annual Report").

**<u>Off-Balance Sheet Arrangements</u>**

As of December 31, 2022, the Company had no off-balance sheet arrangements.

**<u>Critical Accounting Policies</u>**

Our critical accounting policies are described in Management's Discussion and Analysis of Financial Condition and Results of Operations included in our Annual Report. There have been no changes in our critical accounting policies. Our significant accounting policies are described in our notes to the 2022 consolidated financial statements included in our Annual Report.

------

[**Table of Contents**](#toc)

**Item 3. Quantitative and Qualitative Disclosures about Market Risk.**

We are a "smaller reporting company" as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this Item. We do not hold any derivative instruments and do not engage in any hedging activities.

**Item 4. Controls and Procedures.**

**(a)**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Evaluation of Disclosure Controls and Procedures**

The Company, including its principal executive officer and principal financial officer, conducted an evaluation of the effectiveness of the design and operation of its disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the "Exchange Act") as of the end of the period covered by this report (the "Evaluation Date"). Based upon the evaluation, our principal executive officer and principal financial officer concluded as of the Evaluation Date that our disclosure controls and procedures were effective as of the end of the period covered by this Quarterly Report. Based on that evaluation, our management, including the Chief Executive Officer and Chief Financial Officer, concluded that our disclosure controls and procedures were effective in providing reasonable assurance that information required to be disclosed in our reports filed or submitted under the Exchange Act was recorded, processed, summarized, and reported within the time periods specified in the SEC's rules and forms. Disclosure controls are controls and procedures designed to reasonably ensure that information required to be disclosed in our reports filed under the Exchange Act, such as this report, is recorded, processed, summarized, and reported within the time periods specified in the SEC's rules and forms. Disclosure controls include controls and procedures designed to reasonably ensure that such information is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure.

**(b)**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Changes in Internal Control over Financial Reporting**

The Company, including its chief executive officer and chief financial officer, reviewed the Company's internal control over financial reporting, pursuant to Rule 13(a)-15(e) under the Exchange Act and concluded that there was no change in the Company's internal control over financial reporting during the Company's most recently completed fiscal quarter during the period ended December 31, 2022 or subsequent to the date the Company completed its evaluation that has materially affected, or is reasonably likely to materially affect, the Company's internal control over financial reporting.

------

[**Table of Contents**](#toc)

**PART II** – **OTHER INFORMATION**

**Item 1. Legal Proceedings.**

The Aeroflex litigation (see Note 12) to the Unaudited Condensed Consolidated Financial Statements) did not result in a favorable outcome for the Company, despite our belief that we committed no wrongdoing.

The jury found no misappropriation of Aeroflex trade secrets but found that the Company tortiously interfered with a prospective business opportunity and awarded damages. The jury also ruled that Tel tortiously interfered with Aeroflex's non-disclosure agreements with two former Aeroflex employees. The jury also found that the former Aeroflex employees breached their non-disclosure agreements with Aeroflex. The Court conducted further hearings on the Company's post-trial motions which sought to reduce the damages award of $2.8 million, as well as the punitive damages claim. The Court denied the Company's motions and awarded Aeroflex an additional $2.1 million of punitive damages. The Company has filed motions in January 2018 for the Court to reconsider the amount of damages on the grounds that they are duplicative and not legally supportable. The Court heard these motions, and such motions were denied. In 2019 the Company filed for an appeal. The Company has posted a $2 million bond for the appeal. This $2 million bond amount will remain in place during the appeal process (See Note 4).

As reflected in the accompanying unaudited condensed consolidated balance sheet as of December 31, 2022, the Company has recorded estimated damages to date of approximately $6.3 million, including interest, as a result of a jury verdict associated with the Aeroflex litigation. The Company has filed for an appeal (see Notes 4 and 12). As of December 31, 2022, the Company has cash balances of $5.3 million, including $2 million of restricted cash as well as $1.3 million in accounts receivable.

The appeal decision has been delayed due to the COVID-19 related shutdown of the Kansas court system and the inability of court staff to work remotely on confidentiality issues. During August 2021, in an effort to move the appeal forward, all parties agreed to supply the appeal information to the court on a dedicated and secured laptop that would be used by the research attorney remotely. The Company has the ability to settle this case at its sole discretion by withdrawing the appeal and paying the judgment plus interest amount. The Company currently has sufficient cash on hand and borrowing capability to pay off this liability if the appeal is lost.

On January 28, 2022, Aeroflex filed a Motion to Require Supplemental Appeal Bond with the Court of Appeals of the State of Kansas, seeking a bond from the Company in the amount of $6 million to supplement the existing bond of $2 million. The Company has filed a response and we are confident that this motion will be denied.

On October 14, 2022, the Company received an order from the Kansas appellate court of appeals lifting the briefing stay that was entered on March 19, 2020. The Kansas appellate court has notified the Company that the argument has been set for hearing on March 30, 2023 in Topeka, Kansas. A decision on the case is expected approximately 90 days after the conclusion of the arguments. TIC's cash and borrowing position should allow for the payment of the entire amount if necessary. This is based on expected improved fourth quarter results and receipt of the Navy CDR NRE funding.

Other than the matters outlined above, we are currently not involved in any litigation that we believe could have a material adverse effect on our financial condition or results of operations. There is no action, suit, proceeding, inquiry or investigation before any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of executive officers of our Company, threatened against or affecting our Company, or our common stock in which an adverse decision could have a material effect.

**Item 1A. Risk Factors.**

Not applicable because we are a smaller reporting company. Notwithstanding, we believe there are no changes that constitute material changes from the risk factors previously disclosed in the Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2022, filed with the SEC on June 17, 2022.

**Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.**

There were no unregistered sales of the Company's equity securities during the quarter ended December 31, 2022.

**Item 3. Defaults upon Senior Securities.**

There has been no default in the payment of principal, interest, sinking or purchase fund installment, or any other material default, with respect to any indebtedness of the Company during the quarter ending December 31, 2022.

**Item 4. Mine Safety Disclosures.**

Not applicable.

------

[**Table of Contents**](#toc)

**Item 5. Other Information.**

There is no other information required to be disclosed under this item which was not previously disclosed.

**Item 6. Exhibits.**

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| 31.1 | [Certification of Principal Executive Officer, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 302 of 2002\*](ex_472448.htm) |
| 31.2 | [Certification of Principal Financial Officer, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 302 of 2002\*](ex_472449.htm) |
| 32.1 | [Certification of Principal Executive Officer, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002\*](ex_472450.htm) |
| 32.2 | [Certification of Principal Financial Officer, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002\*](ex_472451.htm) |
| 101.INS | Inline XBRL Instance Document\* |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document\* |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document\* |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document\* |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document\* |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document\* |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)\* |

---

\* Filed herewith

------

[**Table of Contents**](#toc)

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **TEL-INSTRUMENT ELECTRONICS CORP.** | **TEL-INSTRUMENT ELECTRONICS CORP.** |
| Date: February 13, 2023 | By: | */s/ Jeffrey C. O*'*Hara* |
|  | Name: | Jeffrey C. O'Hara |
|  | Title: | Chief Executive Officer<br> (Principal Executive Officer) |
| Date: February 13, 2023 | By: | */s/ Pauline Romeo* |
|  | Name: | Pauline Romeo |
|  | Title: | Chief Accounting Officer<br> (Principal Financial and Accounting Officer) |

---

## Exhibit 31.1

**Exhibit 31.1**

**CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER**

**PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 302 OF**

**THE SARBANES-OXLEY ACT OF 2002**

I, Jeffrey C. O'Hara, certify that:

1. I have reviewed this Form 10-Q of Tel-Instrument Electronics Corp.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods present in this report;

4. Along with the Principal Financial Officer, I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13-a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financing reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involved management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| Date: February 13, 2023 | By: | /s/ Jeffrey C. O'Hara |
|  |  | Jeffrey C. O'Hara |
|  |  | Chief Executive Officer <br> (Principal Executive Officer) |

---

## Exhibit 31.2

**Exhibit 31.2**

**CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER**

**PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 302 OF**

**THE SARBANES-OXLEY ACT OF 2002**

I, Pauline Romeo, certify that:

1. I have reviewed this Form 10-Q of Tel-Instrument Electronics Corp.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods present in this report;

4. Along with the Principal Executive Officer, I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13-a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financing reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involved management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| Date: February 13, 2023 | By: | /s/ Pauline Romeo |
|  |  | Pauline Romeo |
|  |  | Chief Accounting Officer<br> (Principal Financial and Accounting Officer) |

---

## Exhibit 32.1

**Exhibit 32.1**

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF**

**THE SARBANES-OXLEY ACT OF 2002**

In connection with this Quarterly Report of Tel-Instrument Electronics Corp. (the "Company"), on Form 10-Q for the quarter ended December 31, 2022, as filed with the U.S. Securities and Exchange Commission on the date hereof, I, Jeffrey C. O'Hara, Principal Executive Officer of the Company, certify to the best of my knowledge, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:

(1) Such Quarterly Report on Form 10-Q for the quarter ended December 31, 2022, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in such Quarterly Report on Form 10-Q for the quarter ended December 31, 2022, fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | | |
|:---|:---|:---|
| Date: February 13, 2023 | By: | /s/ Jeffrey C. O'Hara |
|  |  | Jeffrey C. O'Hara |
|  |  | Chief Executive Officer <br> (Principal Executive Officer) |

---

## Exhibit 32.2

**Exhibit 32.2**

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF**

**THE SARBANES-OXLEY ACT OF 2002**

In connection with this Quarterly Report of Tel-Instrument Electronics Corp. (the "Company"), on Form 10-Q for the quarter ended December 31, 2022, as filed with the U.S. Securities and Exchange Commission on the date hereof, I, Pauline Romeo, Chief Accounting Officer of the Company, certify to the best of my knowledge, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:

(1) Such Quarterly Report on Form 10-Q for the quarter ended December 31, 2022, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in such Quarterly Report on Form 10-Q for the quarter ended December 31, 2022, fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | | |
|:---|:---|:---|
| Date: February 13, 2023 | By: | /s/ Pauline Romeo |
|  |  | Pauline Romeo |
|  |  | Chief Accounting Officer<br> (Principal Financial and Accounting Officer) |

---